A hybrid portfolio blends old and new. Stocks and bonds provide stability; crypto assets like Bitcoin (BTC) and Ethereum (ETH) add innovation and growth potential, but with higher risk. The goal isn’t ...

Amid his dire forecasts, Dalio has repeatedly emphasized the importance of diversification — and singled out one time-tested asset as a cornerstone of a resilient portfolio ... buildings have the ...

In a note issued on October 28, which was released to the media on Friday, the CM emphasised the state's commitment to environmental responsibility and promotion of indigenous products.

A new net zero recycling tax will increase NHS drug prices, a major pharmaceutical maker has warned. Teva Pharmaceuticals, which supplies one in seven prescriptions in the UK, said a new eco levy will ...

Matt Swain has become a pioneer by pairing family offices looking to triple their money with under-the-radar businesses ...

In our Zenfolio review, we take a close look at this popular portfolio builder, highlighting its main pros and cons.

After decades of Australian governments standing by while native species perish, Labor’s new environment bill offers little ...

Tens of thousands of Americans are losing jobs. It doesn't have to ruin you financially. Here are some survival tips.

COMPUCHILD, a leading provider of Entrepreneurial STEAMtm-focused after-school education programs for children, is pleased to announce the addition of its newest franchisee, serving the cities of ...

Enterprises across the U.S. are working with AWS and its partner ecosystem to accelerate cloud modernization and rapidly scale their use of AI, according to a new research report published today by ...

"The PEA highlights the strong value Diamba Sud brings to Fortuna's portfolio, using a long-term gold price of $2,750 per ... "With permitting and the Definitive Feasibility Study underway, we expect ...

Arcutis Biotherapeutics recently launched ZORYVE cream 0.05% in the United States for mild to moderate atopic dermatitis in children aged 2 to 5, expanding its ZORYVE portfolio following FDA approval ...